AR086395A1 - Envase para el tratamiento de patologias - Google Patents

Envase para el tratamiento de patologias

Info

Publication number
AR086395A1
AR086395A1 ARP120101704A ARP120101704A AR086395A1 AR 086395 A1 AR086395 A1 AR 086395A1 AR P120101704 A ARP120101704 A AR P120101704A AR P120101704 A ARP120101704 A AR P120101704A AR 086395 A1 AR086395 A1 AR 086395A1
Authority
AR
Argentina
Prior art keywords
package
active ingredients
provides
pathologies
treatment
Prior art date
Application number
ARP120101704A
Other languages
English (en)
Inventor
Edmundo Muniz
Maninder Chopra
Neil Flanzraich
Joseph Pergolizzi
Original Assignee
Kirax Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirax Corp filed Critical Kirax Corp
Publication of AR086395A1 publication Critical patent/AR086395A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La presente brinda un envase a partir de la administración de ingredientes activos. La presente brinda un envase que comprende: una porción estándar que comprende uno o más ingredientes activos en una pluralidad de potencias diferentes, y una porción de rescate que comprende uno o más ingredientes activos iguales o diferentes. La presente brinda además un kit que comprende un envase que comprende una porción estándar, que comprende uno o más ingredientes activos en una pluralidad de potencias diferentes, y un módulo de evaluación de pacientes que comprende instrucciones para la administración de la porción estándar. El envase puede opcionalmente comprender además una porción de rescate.
ARP120101704A 2011-05-11 2012-05-11 Envase para el tratamiento de patologias AR086395A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161485019P 2011-05-11 2011-05-11
US201161496647P 2011-06-14 2011-06-14

Publications (1)

Publication Number Publication Date
AR086395A1 true AR086395A1 (es) 2013-12-11

Family

ID=47139705

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101704A AR086395A1 (es) 2011-05-11 2012-05-11 Envase para el tratamiento de patologias

Country Status (4)

Country Link
US (2) US20120289534A1 (es)
AR (1) AR086395A1 (es)
TW (1) TW201306825A (es)
WO (1) WO2012155091A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2968072B1 (en) * 2013-03-14 2018-09-12 Cephalon, Inc. Child resistant cover for oral dosage forms
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9828158B2 (en) 2014-04-03 2017-11-28 Toyota Motor Engineering & Manufacturing North America, Inc. Packaging for visually impaired and blind persons
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
KR20180072713A (ko) 2015-10-01 2018-06-29 고레이니 인크. 클로라이드 채널의 표적된 발현 및 이의 사용 방법
US11147780B2 (en) * 2020-02-24 2021-10-19 Algia Pharma, Llc Multidrug pain management package

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001504372A (ja) * 1996-11-19 2001-04-03 ザ プロクター アンド ギャンブル カンパニー コンプライアンスパッケージおよび複合薬の投与計画に関して患者コンプライアンスを改良するかまたは補助するための方法
US6375957B1 (en) * 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
US7156089B2 (en) * 2002-06-19 2007-01-02 Weinstein Robert E Method and device for treatment of respiratory tract disorders
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2005115360A2 (en) * 2004-05-11 2005-12-08 Becton, Dickinson And Company Formulations of anti-pain agents and methods of using the same
US20110101016A1 (en) * 2009-09-25 2011-05-05 Edge Medical Properties, Llc Low vision patient compliant medication management system and method
US20080110792A1 (en) * 2006-11-09 2008-05-15 Orexigen Therapeutics, Inc. Methods for administering weight loss medications

Also Published As

Publication number Publication date
TW201306825A (zh) 2013-02-16
US20190365678A1 (en) 2019-12-05
WO2012155091A1 (en) 2012-11-15
US20120289534A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
AR086395A1 (es) Envase para el tratamiento de patologias
FR21C1025I2 (fr) Composition parasiticide comprenant un agent actif d'isoxazoline, son procede et utilisation
CR20150326A (es) Inhibidores de autotaxina
CL2014002077A1 (es) Composicion farmaceutica que comprende fumarato de dimetilo; metodo de preparacion; capsula que comprende microtabletas de fumarato de dimetilo; metodo para el tratamiento, profilaxis o mejora de la esclerosis multiple.
CL2015001792A1 (es) Una composicion que comprende (i) un complejo de haluro de (aminoacido o trialquil glicina) y zinc y (ii) cisteina, util para la eliminacion de las bacterias, la reduccion de la transpiracion y/o la reduccion del olor corporal, o para el cuidado oral, entre otras.
MD4577C1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
UY34358A (es) ?tratamiento de la esclerosis múltiple con una combinación de laquinimod y acetato de glatiramer?.
UY33396A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
UY32177A (es) Tratamiento de diabetes en pacientes con control glucémico insuficiente a pesar de la terapia con fármaco, oral o no, antidiabético
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
IN2012DN06309A (es)
EA201390799A1 (ru) Триазолопиридины
BR112013011259A2 (pt) condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
MX2014005895A (es) Medicamento para tratamiento terapeutico y/o mejoramiento de sepsis.
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
CO2017007316A2 (es) Formulación farmacéutica
CL2013001684A1 (es) Composicion farmaceutica de administracion oral que comprende alisporivir, un componente lipofilico, un tensoactivo y un componente hidrofilico.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal